A 60-year-old man with unstable angina is treated with an intravenously administered glycoprotein IIb-IIIa inhibitor. The mechanism of action of this agent is the ability to
Dilate coronary aeries. Inhibit atherogenesis. Inhibit platelet adhesion. Inhibit platelet aggregation.